Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

United Medical College Hospital

Tracked across 2 events · 12 articles · First seen Aug 31, 2026 · Last active Sep 10, 2026

Sentiment
25
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 10
Tech
Insilico Medicine announced on September 9-10, 2026 that it has dosed the first patient with Rentosertib (ISM001-055 / INS018_055) in GENESIS-IPF-3, a Phase III clinical trial for idiopathic pulmonary fibrosis (IPF), at United Medical College…
Impact: United Medical College Hospital is the site where the first patient was dosed and is led by the trial's Leading Principal Investigator, Professor Zuojun Xu. Its involvement underscores its role in advancing clinical research for IPF.
Sep 10, 2026 · 6 articles
2 40
Tech
Impact: The hospital where the surgeries were performed, benefiting from the milestone and associated publicity.
Aug 31, 2026 · 6 articles
ERGEN INTELLIGENCE
Track United Medical College Hospital live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.